| |
No. (%)
|
|---|
|
Gender
| |
|
Male
|
103(72.5)
|
|
Female
|
39(27.5)
|
|
Age (years)
| |
|
≤ 65
|
89(62.7)
|
|
>65
|
53(37.3)
|
|
Pathology
| |
|
Squamous cell carcinoma
|
47(33.1)
|
|
Adenocarcinoma
|
68(47.9)
|
|
Adenosquamous carcinoma
|
27(19.0)
|
|
NSCLC histology (AJCC grade)
| |
|
I
|
32(22.5)
|
|
II
|
25(17.6)
|
|
III
|
58(40.8)
|
|
IV
|
27(19.0)
|
|
Survival (n = 89)
| |
|
Alive
|
33(37.1)
|
|
Dead
|
56(62.9)
|
|
Survial time of low expression
| |
|
Mean 31.70
| |
|
Median 28.50
| |
|
Survival time of high expression
| |
|
Mean 24.84
| |
|
Median 24.00
| |
|
Expression of SOX9
| |
|
Negative
|
7(4.9)
|
|
Positive
|
135(95.1)
|
|
Low expression
|
68(47.9)
|
|
High expression
|
74(52.1)
|
